Art

J-GLOBAL ID：202002230759292041   Reference number：20A2090278

Reappraisal of Oral Steroid Therapy for Myasthenia Gravis

重症筋無力症に対する経口ステロイド療法の再評価【JST・京大機械翻訳】

Author (6)： Imai Tomihiro (Department of Neurology, Sapporo Medical University Hospital, Sapporo, Japan) ,  Suzuki Shigeaki (Department of Neurology, Keio University School of Medicine, Tokyo, Japan) ,  Nagane Yuriko (Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan) ,  Uzawa Akiyuki (Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan) ,  Murai Hiroyuki (Department of Neurology, International University of Health and Welfare, Narita, Japan) ,  Utsugisawa Kimiaki (Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan)
Material： Frontiers in Neurology (Web)
Volume： 11  Page： 868  Publication year： 2020 
JST Material Number： U7085A  ISSN： 1664-2295  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Treatment with oral corticoste...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2090278&from=J-GLOBAL&jstjournalNo=U7085A") }}

Thesaurus term： immunoglobulin ,  Mortality ,  vein ,  adrenocortical hormone ,  *myasthenia ,  therapeutic planning ,  plasma exchange ,  *myasthenia gravis ,  low dosage ,  high dosage ,  Calcineurin Inhibitors ,  *steroid hormone therapy ,  Japanese
Semi thesaurus term： 治療標的 ,  治療目標 , 【Automatic Indexing@JST】

Author keywords (5)： myasthenia gravis ,  oral corticosteroids ,  treatment strategies ,  cross-sectional study ,  logistic regression analysis

JST classification (3)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Treatment for immunologic diseases,allergic diseases.  (GD04030Y) ,  Nervous system diseases  (GN03000O)

Reference (50)：

• Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. (2009) 8:475-90. doi: 10.1016/S1474-4422(09)70063-8
• Bromberg MB, Wald JJ, Forshew DA, Feldman EL, Albers JW. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. J Neurol Sci. (1997) 150:59-62. doi: 10.1016/S0022-510X(97)05370-7
• Myasthenia Gravis Study Group. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of a second interim analysis. J Neurol Neurosurg Psychiatry. (1993) 56:1157-63. doi: 10.1136/jnnp.56.11.1157
• Tindall RS, Phillips JT, Rollins JA, Wells L, Hall K. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci. (1993) 681:539-51. doi: 10.1111/j.1749-6632.1993.tb22937.x
• Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology. (2008) 71:394-9. doi: 10.1212/01.wnl.0000312373.67493.7f

Terms in the title (3)： 重症筋無力症 ,  ステロイド療法 ,  評価